Levels of pro-inflammatory cytokines and chemokines including CXCL10, IFNα, IFNβ, IL-1b and TNFα increased with treatment in the majority of the melanoma tumoursphere lines tested (Figure 1B). This evidence concerns the gene IL1B and melanoma.